{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:48:42Z","timestamp":1784252922827,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jaad.2016.12.027","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T09:15:54Z","timestamp":1488964554000},"page":"948-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients"],"prefix":"10.1016","volume":"76","author":[{"given":"Athina","family":"Fonia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane F.","family":"Setterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Stefanato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.12.027_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0738-081X(00)00127-9","article-title":"The psychology of hair loss and its implications for patient care","volume":"19","author":"Cash","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib2","first-page":"147","article-title":"Hair and cancer chemotherapy: consequences and nursing care\u2014a literature study","volume":"10","author":"Batchelor","year":"2001","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.jaad.2016.12.027_bib3","first-page":"5","article-title":"Chemotherapy-induced hair loss","volume":"15","author":"Trueb","year":"2010","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jaad.2016.12.027_bib4","first-page":"43","article-title":"Busulphan\/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth","volume":"7","author":"Baker","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2016.12.027_bib5","first-page":"869","article-title":"Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants","volume":"15","author":"Ljungman","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2016.12.027_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1440-0960.2000.00405.x","article-title":"Permanent alopecia following chemotherapy and bone marrow transplantation","volume":"41","author":"Tran","year":"2000","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bmt.1703695","article-title":"Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy","volume":"30","author":"de Jonge","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2016.12.027_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2005.06469.x","article-title":"Permanent alopecia after busulfan chemotherapy","volume":"152","author":"Tosti","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bmt.1705817","article-title":"Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation","volume":"40","author":"Machado","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2016.12.027_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000102031","article-title":"Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation","volume":"215","author":"Yun","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2016.12.027_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2133.2009.09043.x","article-title":"Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer","volume":"160","author":"Prevezas","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","article-title":"Permanent chemotherapy-induced alopecia: case report and review of the literature","volume":"63","author":"Tallon","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/DAD.0b013e3181fcfc25","article-title":"Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases","volume":"33","author":"Miteva","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2016.12.027_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1529-8019.2011.01430.x","article-title":"Treatment of chemotherapy-induced alopecia","volume":"24","author":"Yeager","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2016.12.027_bib15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2010.03.020","article-title":"Permanent chemotherapy-induced alopecia: a review","volume":"64","author":"Palamaras","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib16","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2016.12.027_bib17","series-title":"An Atlas of Hair Pathology with Clinical Correlations","first-page":"194","article-title":"Chemotherapy-induced alopecia","author":"Sperling","year":"2012"},{"key":"10.1016\/j.jaad.2016.12.027_bib18","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.jaad.2010.07.019","article-title":"Permanent chemotherapy-induced alopecia: histopathologic criteria still to be defined","volume":"68","author":"Tallon","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.0022-202X.2005.23787.x","article-title":"A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice","volume":"125","author":"Hendrix","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib20","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jaad.2011.02.026","article-title":"Chemotherapy-induced alopecia","volume":"67","author":"Chon","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib21","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/jidsymp.2013.7","article-title":"The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives","volume":"16","author":"Paus","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2016.12.027_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1592\/phco.23.1.104.31918","article-title":"Recurring chemotherapy-associated alopecia areata: case report and literature review","volume":"23","author":"Motl","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaad.2016.12.027_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2133.2005.06608.x","article-title":"\u201cAtrophic telogen effluvium\u201d from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans","volume":"153","author":"Bleiker","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.314.7079.481","article-title":"Alopecia and breast disease","volume":"314","author":"Gateley","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2016.12.027_bib25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1346-8138.2012.01632.x","article-title":"Female pattern hair loss possibly caused by tamoxifen: androgen receptor expression in the outer root sheath in the affected area","volume":"39","author":"Nonomura","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-126-9-199705010-00033","article-title":"Tamoxifen-induced female androgenetic alopecia in a patient with breast cancer","volume":"126","author":"Ayoub","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2016.12.027_bib27","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.7326\/0003-4819-134-12-200106190-00029","article-title":"Tamoxifen-induced total alopecia","volume":"134","author":"Puglisi","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2016.12.027_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5021\/ad.2014.26.6.743","article-title":"Pattern alopecia during hormonal anticancer therapy in patients with breast cancer","volume":"26","author":"Park","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib29","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/annonc\/mdg444","article-title":"Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin","volume":"14","author":"Carlini","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2016.12.027_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2133.2010.09772.x","article-title":"Tamoxifen-loaded liposomal topical formulation arrests hair growth in mice","volume":"163","author":"Bhatia","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.027_bib31","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/en.2004-1219","article-title":"Hair cycle control by estrogens: catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling","volume":"146","author":"Ohnemus","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaad.2016.12.027_bib32","doi-asserted-by":"crossref","unstructured":"Yang X, Thai KE. Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil [e-pub ahead of print]. Australas J Dermatol. http:\/\/dx.doi.org\/10.1111\/ajd.12350. Accessed January 8, 2017.","DOI":"10.1111\/ajd.12350"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:42:42Z","timestamp":1759272162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216312889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0190962216312889"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.027","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}